Gelesis200 Safety and Tolerability Study and Effects on Glycemic and Appetite Parameters

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Healthy Overweight Obese

Interventions

DEVICE

Gelesis200

3 capsules each containing 0.70 g

OTHER

Placebo

3 capsules each containing 0.57 g of a mixture of microcrystalline cellulose and maltodextrin in a ratio of approximately 50 ± 10%

Trial Locations (1)

Québec